In this study, we explored the regulation and the role of up-regulated microRNAs in
idiopathic pulmonary fibrosis (IPF), a progressive interstitial lung disease of unknown origin …

In this review, we describe the recent advances in the understanding of the role of
microRNAs in idiopathic pulmonary fibrosis (IPF), a chronic progressive and lethal fibrotic …

Excessive extracellular matrix production by fibroblasts in response to tissue injury
contributes to fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF). Epithelial …

Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive
remodeling of lungs, with no known effective treatment. Although transforming growth factor …

Many studies have shown that microRNAs (miRNAs) play important roles in the
development of idiopathic pulmonary fibrosis (IPF). The purpose of this review is to …

Transforming growth factor (TGF)-β1, a main profibrogenic cytokine in the progression of
idiopathic pulmonary fibrosis (IPF), induces differentiation of pulmonary fibroblasts to …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial lung disease
of unknown etiology that is currently untreatable. In this study we aim to characterize the …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal scarring lung disease
of unknown etiology, characterized by changes in microRNA expression. Activation of …

Pulmonary fibrosis is the most common form of interstitial lung disease. The transforming
growth factor-β (TGF-β) signaling pathway is extensively involved in the development of …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and high-lethality fibrotic lung
disease characterized by excessive fibroblast proliferation, extracellular matrix …